170907 ⎘
Detection or diagnosis of diseases; Mechanisms involved in disease identification Aging, e.g. cellular aging
TREATMENTS FOR CELLULAR REJUVENATION
#2DIAGNOSTIC METHOD OF A SKIN SHOWING SIGNS OF AGING
#3ORGAN AGING BIOMARKERS DERIVED FROM THE PLASMA PROTEOME
#4BIOMARKERS
#5PRODUCTS AND METHODS FOR ASSESSING AND INCREASING KLOTHO PROTEIN LEVELS
#6CELL-FREE DNA END CHARACTERISTICS
#7SYSTEM AND METHOD FOR CELL LEVITATION AND MONITORING
#8COMPOSITIONS AND METHODS FOR ASSESSING AND TREATING AGE-RELATED CONDITIONS
#9ANTIBODY BINDING A LINEAR EPITOPE OF HUMAN P53 AND DIAGNOSTIC APPLICATIONS THEREOF
#10METHOD FOR IDENTIFYING AND/OR REGULATING SENESCENCE
#11COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING PATIENTS WITH A HISTORY OF EARLY LIFE ADVERSITY
#12METHODS FOR USE IN PREVENTATIVE HEALTHCARE
#13EGG, FERTILIZED EGG, OR EMBRYO QUALITY IMPROVING AGENT
#14REAL-TIME FLUORESCENCE IMAGING SENSOR FOR MEASURING GLUTATHIONE IN ENDOPLASMIC RETICULUM AND METHOD USING SAME
#15UTILIZATION OF A FASTING-MIMICKING DIET TO REDUCE SENESCENT CELLS AND INFLAMMATION
#16Antibody binding a linear epitope of human P53 and diagnostic applications thereof
#17COMPOSITIONS FOR THE ELIMINATION OF SENESCENT CELLS
#18System and method for cell levitation and monitoring
#19METHODS AND COMPOSITIONS FOR DETECTION AND VISUALIZATION OF OXIDATIVE STRESS-INDUCED CARBONYLATION IN CELLS
#20Method of assessing aging of erythrocytes
#21Egg, fertilized egg, or embryo quality improving agent
#22Antibody binding a linear epitope of human P53 and diagnostic applications thereof
#23Antibody binding a linear epitope of human P53 and diagnostic applications thereof
#24BIOMARKER FOR SENESCENT CELLS
#25DIAGNOSTIC METHOD OF A SKIN SHOWING SIGNS OF AGING
#26CELL-FREE DNA END CHARACTERISTICS
#27DIAGNOSTIC ADVANCED GLYCATION END-PRODUCT ANTIBODIES
#28Biomarker of aging
#29Methods for in vitro investigating mitochondrial replication dysfunction in a biological sample, kits and uses thereof, therapeutic methods against progeroid-like syndromes or symptoms and screening method for identifying particular protease inhibitor(s) and/or nitroso-redox stress scavenger compound(s)
#30BIOENERGETIC PROFILING OF CIRCULATING BLOOD CELLS AND SYSTEMS, DEVICES, AND METHODS RELATING THERETO
#31GROWTH HORMONE RECEPTOR DEFICIENCY CAUSES A MAJOR REDUCTION IN PRO-AGING SIGNALING, CANCER AND DIABETES IN HUMANS
#32Methods and systems for determining the biological age of samples
#33Real-time imaging sensor for measuring cellular thiol level
#34Antibody binding a linear epitope of human p53 and diagnostic applications thereof
#35METHOD FOR DETERMINING THE EXTENT OF AGING OF A SUBJECT AND TREATING THE SUBJECT TO SUPPRESS THE EXTENT OF AGING
#36LAMIN A/C AND PRELAMINS AS INDICATORS OF FRAILTY AND VULNERABILITY OR RESILIENCY TO ADVERSE HEALTH OUTCOMES
#37Methods for treating sarcopenia and frailty
#38BIOENERGETIC PROFILING OF CIRCULATING BLOOD CELLS AND SYSTEMS, DEVICES, AND METHODS RELATING THERETO
#39METHOD OF DIGITIZING NUTRITIONAL STATUS, MUSCLE TURNOVER, AND RISK ASSESSMENT
#40Antibody binding a linear epitope of human p53 and diagnostic applications thereof
#41AGE-MODIFIED CELLS AND METHODS FOR MAKING AGE-MODIFIED CELLS
#42Real-time imaging sensor for measuring cellular thiol level
#43COMPLIMENT FACTOR I BIOASSAY
#44Methods, agents and compositions for treatment of inflammatory conditions
#45Methods for in vitro investigating mitochondrial replication dysfunction in a biological sample, kits and uses thereof, therapeutic methods against progeroid-like syndromes or symptomes and screening method for identifying particular protease inhibitor(s) and/or nitroso-redox stress scavenger compound(s)
#46Aurantiamide dipeptide derivatives for treatment or prevention of angiogenesis-related diseases
#47In vitro assays for assessing cell aging
#48Inhibitors of thioredoxin-interacting protein (TXNIP) for therapy
#49System and method for cell levitation and monitoring
#50LAMIN A/C AND PRELAMINS AS INDICATORS OF FRAILTY AND VULNERABILITY OR RESILIENCY TO ADVERSE HEALTH OUTCOMES
#51METHODS, AGENTS AND COMPOSITIONS FOR TREATMENT OF INFLAMMATORY CONDITIONS
#52Methods for the diagnosis and risk assessment of plasmalogen deficiency mediated diseases of aging
#53High-Throughput Yeast-Aging Analysis (HYAA) Chip For Performing Yeast Aging Assays
#54BIOMARKERS ASSOCIATED WITH AGE-RELATED MACULAR DEGENERATION
#55DETECTION OF ALPHA, BETA-DICARBONYL COMPOUNDS WITH FLUOROGENIC PROBES
#56COMPLEMENT ASSAYS AND USES THEREOF
#57COMPOSITION, FORMULATIONS AND METHODS OF MAKING AND USING BOTANICALS AND NATURAL COMPOUNDS FOR THE PROMOTION OF HEALTHY BRAIN AGING
#58NOVEL ASSAY
#59Biomarkers Related To Metabolic Age and Methods Using The Same
#60Method for the analysis of N-glycans attached to immunoglobulin G from human blood plasma and its use
#61MARKER FOR DIAGNOSING AGE-RELATED MACULAR DEGENERATION, AND METHOD FOR DIAGNOSING AGE-RELATED MACULAR DEGENERATION BY USING SAME
#62Senescence tracers
#63HYDROXY-SPHINGOMYELIN 22:1 AS A BIOMARKER FOR HEALTHY AGING
#64Phenylacetylglutamine as a biomarker for healthy aging
#65PC-O 40:1 as a biomarker for healthy aging
#66P-cresol sulphate as a biomarker for healthy aging
#67Markers of papillary and reticular fibroblasts and uses thereof
#68hnRNP A1 knockout animal model and use thereof
#69Pharmaceutical composition for treating aging-associated diseases, containing progerin expression inhibitor as active ingredient, and screening method of said progerin expression inhibitor
#70Procalcitonin gene expression as a precise biomarker of aging process
#71hnRNP A1 KNOCKOUT ANIMAL MODEL AND USE THEREOF
#72Epigenetic mechanisms related to DNA damage and aging
#73Method for evaluating cell aging by expression level of cofilin
#74Biomarker-based methods for identifying and formulating compositions that improve skin quality and reduce the visible signs of aging in skin
#75Complement assays and uses thereof
#76Biomarkers Related To Metabolic Age and Methods Using The Same
#77METHODS FOR THE DIAGNOSIS AND RISK ASSESSMENT OF PLASMALOGEN DEFICIENCY MEDIATED DISEASES OF AGING
#78Biomarkers Associated With Age-Related Macular Degeneration
#79Biomarkers related to metabolic age and methods using the same